Latest Mergers And Acquisitions News

Resonance Health reports a solid quarter with key clinical trial milestones, expansion of trial sites, and multi-year Software-as-a-Medical Device contracts, underpinning a positive cashflow outlook.

IODM Limited reported a robust 37% increase in cash receipts for Q4 FY25, driven by strong UK education sector growth and new international revenue share agreements.

Starpharma reports a 165% rise in FY25 customer receipts, advances its clinical-stage DEP® assets, and secures new distribution deals in Asia and Saudi Arabia.

FirstWave Cloud Technology reports a slight revenue decline in Q4 FY25, offsets challenges with strategic restructuring and a new AWS marketplace partnership.

Energy Metals Limited reported steady progress in its uranium exploration projects during the June 2025 quarter, supported by a strong cash position and rising uranium prices. Preparations to refresh the Bigrlyi Pre-Feasibility Study and regional exploration groundwork highlight the company’s strategic focus.

Australian Critical Minerals has acquired six exploration projects in Peru, significantly broadening its portfolio with targets in gold, copper, silver, base metals, and lithium. The company also completed a $1 million capital raise to fund upcoming exploration activities.

Hydrix Limited reports steady June quarter revenues with a 10% rise from the prior quarter, supported by new contract wins and a robust $40 million project pipeline.

HALO Technologies reports $3.54 million in Q2 revenue with rising subscription income, progressing UK expansion pending FCA approval, and a $6.75 million capital raise nearing completion.

Beacon Minerals reported a 20% increase in gold production to 7,365 ounces in the June 2025 quarter, alongside significant drilling progress at the Iguana deposit and a strategic share consolidation and buy-back program.

Galilee Energy reported operational cost reductions and a $2.8 million cash balance following a partial capital raise, while progressing a farm-out process for its Denison Trough permit.

Blue Star Helium has completed flow testing at its Mula well in Colorado, revealing robust gas flow rates and a helium concentration above regional norms, bolstering the asset’s commercial promise.

Imugene Limited reports strong clinical progress with its off-the-shelf CAR T therapy azer-cel achieving a 75% overall response rate in Phase 1b trials, alongside new patents and leadership appointments. The company also secured $22.5 million in fresh funding to advance pivotal trials.